Versartis (VSAR) Reports Merger Agreement with Aravive Biologics Jun 4, 2018 08:05AM
Versartis Enters into Merger Agreement with Aravive Biologics to Form a Clinical-Stage Biopharmaceutical Company Advancing Innovative Oncology Therapeutics Jun 4, 2018 08:00AM
Eyenovia Appoints Three Industry Veterans to Board of Directors Mar 26, 2018 04:05PM
Versartis Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update Mar 1, 2018 04:05PM
Versartis (VSAR) Taps Cowen to Assist in Evaluating Potential Strategic Transactions Oct 26, 2017 04:27PM


Oct 26, 2017 04:05PM Versartis Hires Cowen to Assist in Evaluating Potential Strategic Transactions
Sep 22, 2017 09:29AM Pre-Open Movers 09/22: (ASND) (SVRA) (S) Higher; (VSAR) (ICPT) (FINL) Lower (more...)
Sep 22, 2017 05:34AM Cowen Downgrades Versartis (VSAR) to Market Perform
Aug 23, 2017 06:17AM Cowen Reiterates Bullish View on Versartis (VSAR) Following Postive Soma KOL Survey; Worth $65+ in Take-Out
Mar 1, 2017 04:36PM Versartis to Present at Cowen & Co. Annual Healthcare Conference and Barclays Global Healthcare Conference
Sep 28, 2016 09:04AM Versartis (VSAR) Prices 4.9M Offering of Common Stock at $12.25/Share
Sep 28, 2016 09:02AM Versartis Announces Pricing of Follow-On Offering
Sep 27, 2016 04:01PM Versartis (VSAR) Announces Common Stock Offering
Sep 27, 2016 04:01PM Versartis Announces Proposed Offering of Common Stock
Mar 1, 2016 04:05PM Versartis to Present at the Cowen and Company 36th Annual Health Care Conference
Sep 15, 2015 01:00PM Versartis (VSAR) Bounces Off Session Lows After Earlier Modifying Trial
Feb 23, 2015 04:05PM Versartis to Present at the Cowen and Company 35th Annual Health Care Conference
Jan 21, 2015 08:44PM Versartis Announces Pricing of Follow-On Offering
Jan 20, 2015 06:12AM Versartis (VSAR) Announces $75M Common Offering
Jan 20, 2015 06:10AM Versartis Announces Proposed Offering of Common Stock
Apr 15, 2014 10:11AM Cowen Starts Versartis (VSAR) at Outperform
Mar 26, 2014 04:05PM Versartis Announces Closing of Its Initial Public Offering and Full Exercise of Over-Allottment Option
Mar 21, 2014 10:54AM Versartis (VSAR) IPO Lights Up Wall Street
Mar 21, 2014 06:38AM Versartis (VSAR) IPO Prices at Top End of Range
Mar 20, 2014 09:35PM Versartis Announces Pricing of Its Initial Public Offering